Regenerative lung therapies: promise, mechanism and accountability

We are grateful for conference grant support from the National Institutes of Health, National Heart, Lung, and Blood Institute, R13HL182312 (to DJW and ALR); National Science Foundation, Division of Chemical, Bioengineering, Environmental, and Transport Systems #22516052 (to ALR); The Company of Biologists Conference Award (to ALR), and The Cystic Fibrosis Foundation, CELLBIO25XX0-CONF. We are also grateful for conference support from the Pulmonary Fibrosis Foundation (PFF), the International Society of Cell and Gene Therapy (ISCT), Agilent, Genentech, United Therapeutics, Scireq, and Boehringer Ingelheim. In addition, we would like to thank the Vermont Academy of Science and Engineering, the Continuing Medi-cal Education Office at the University of Vermont, the University of Vermont and the Larner College of Medicine for their continued physical and financial support of the Stem Cells, Cell Therapies and Bioengineering in Lung Biology and Diseases Conference.